Avidity Biosciences, Inc.

NasdaqGM:RNA Stock Report

Market Cap: US$2.5b

Avidity Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:RNA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Apr 24SellUS$542,214Arthur LevinIndividual20,000US$27.11
12 Mar 24SellUS$58,102Arthur LevinIndividual2,641US$22.00
26 Jan 24BuyUS$2,152,651RTW Investments, LPCompany207,780US$10.49
22 Jan 24SellUS$16,370Michael MacLeanIndividual1,616US$10.13
22 Jan 24SellUS$20,918Teresa McCarthyIndividual2,065US$10.13
22 Jan 24SellUS$120,173RTW Investments, LPCompany11,700US$10.27

Insider Trading Volume

Insider Buying: RNA insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of RNA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies21,5730.0226%
Individual Insiders367,2690.384%
VC/PE Firms4,895,9595.12%
Public Companies5,075,3045.31%
General Public7,738,6158.09%
Hedge Funds7,909,2698.27%
Institutions69,616,82972.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35%.


Top Shareholders

Top 25 shareholders own 80.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.9%
FMR LLC
10,404,084US$270.1m-6.39%0.02%
10.1%
T. Rowe Price Group, Inc.
9,656,852US$250.7m39.7%0.02%
8.27%
RTW Investments, LP
7,909,269US$205.3m18.2%3.71%
6.79%
BlackRock, Inc.
6,496,593US$168.7m12.3%no data
5.89%
Cowen Inc,Private Banking and Investment Banking Investments
5,629,103US$146.1m0%5.44%
5.31%
Bristol-Myers Squibb Company
5,075,304US$131.8m0%no data
5.12%
RA Capital Management, L.P.
4,895,959US$127.1m99.5%1.71%
4.23%
The Vanguard Group, Inc.
4,043,179US$105.0m0.71%no data
3.6%
State Street Global Advisors, Inc.
3,438,328US$89.3m-17.4%no data
2.62%
Avoro Capital Advisors LLC
2,510,000US$65.2m0%0.98%
2.2%
Artisan Partners Limited Partnership
2,103,022US$54.6m-2.36%0.05%
1.67%
Adage Capital Management, L.P.
1,600,000US$41.5m23.1%0.08%
1.62%
Geode Capital Management, LLC
1,547,214US$40.2m7.78%no data
1.57%
Dimensional Fund Advisors LP
1,499,773US$38.9m-5.73%0.01%
1.43%
Morgan Stanley, Investment Banking and Brokerage Investments
1,363,375US$35.4m33.2%no data
1.27%
Balyasny Asset Management L.P.
1,215,837US$31.6m-39.8%0.09%
1.23%
Casdin Capital, LLC
1,175,750US$30.5m-5.94%2.61%
1.17%
Tavistock Life Sciences
1,121,327US$29.1m0%1.75%
0.91%
JP Morgan Asset Management
865,654US$22.5m-5.25%no data
0.89%
Alethea Capital Management, LLC
854,651US$22.2m0%23.14%
0.81%
Logos Global Management, L.P.
775,000US$20.1m0%2.54%
0.8%
Deutsche Asset & Wealth Management
762,849US$19.8m467%0.01%
0.7%
Two Sigma Investments, LP
667,533US$17.3m18.5%0.04%
0.7%
5AM Venture Management, LLC
665,555US$17.3m0%3.41%
0.69%
Northern Trust Global Investments
662,868US$17.2m3.52%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.